androstenedione has been researched along with mifepristone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| de Jong, FH; Koper, JW; Lamberts, SW | 1 |
| Alexieva-Figusch, J; Bakker, GH; de Jong, FH; Klijn, JG; Lamberts, SW; Rodenburg, CJ | 1 |
| Gorodeski, GI; Sheean, LA; Utian, WH | 1 |
| Kettel, LM; Morales, AJ; Murphy, AA; Roberts, VJ; Yen, SS | 1 |
| Aguado, LI; Carrizo, DG; Deis, RP; Rastrilla, AM; Stati, AO; Stocco, CO; Tellería, CM | 1 |
| Gordon, K; Heikinheimo, O; Hodgen, GD; Williams, RF | 1 |
| Grunberg, S; Heikinheimo, O; Lähteenmäki, P; Ranta, S; Spitz, IM | 1 |
| Bratoeff, E; Cabeza, M; Garcés, M; García-Lorenzana, M; Heuze, I; Teran, N | 1 |
11 other study(ies) available for androstenedione and mifepristone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The endocrine effects of long-term treatment with mifepristone (RU 486).
Topics: Adrenocorticotropic Hormone; Adult; Aged; Androgens; Androstenedione; Brain Neoplasms; Circadian Rhythm; Corticotropin-Releasing Hormone; Dexamethasone; Estradiol; Estrogens; Female; Humans; Hydrocortisone; Male; Meningioma; Middle Aged; Mifepristone; Nausea; Vomiting | 1991 |
Antiprogestins, a new form of endocrine therapy for human breast cancer.
Topics: Aged; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrenes; Female; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Mifepristone | 1989 |
Sex hormone modulation of flow velocity in the parametrial artery of the pregnant rat.
Topics: Androstenedione; Animals; Arteries; Blood Flow Velocity; Estradiol; Female; Gonadal Steroid Hormones; Mifepristone; Models, Biological; Placental Circulation; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Time Factors; Uterus | 1995 |
Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Topics: Adolescent; Adult; Androstenedione; Bone Density; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Hysterectomy; Immunohistochemistry; Leiomyoma; Luteinizing Hormone; Middle Aged; Mifepristone; Myometrium; Progesterone; Receptors, Estradiol; Receptors, Progesterone; Testosterone; Uterine Neoplasms | 1993 |
Dual regulation of luteal progesterone production by androstenedione during spontaneous and RU486-induced luteolysis in pregnant rats.
Topics: 17-Hydroxysteroid Dehydrogenases; 20-alpha-Hydroxysteroid Dehydrogenase; 20-Hydroxysteroid Dehydrogenases; Adrenalectomy; Androstenedione; Animals; Aromatase Inhibitors; Cells, Cultured; Corpus Luteum; Dihydrotestosterone; Estradiol; Female; Hormone Antagonists; Luteolysis; Luteolytic Agents; Menstruation-Inducing Agents; Mifepristone; Organ Size; Polyunsaturated Alkamides; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Wistar; Testosterone | 1995 |
Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Topics: Analysis of Variance; Androstenedione; Animals; Contraceptive Agents, Female; Estradiol; Female; Follicle Stimulating Hormone; Hypothalamus; Levonorgestrel; Luteinizing Hormone; Macaca fascicularis; Menstruation-Inducing Agents; Mifepristone; Ovarian Follicle; Ovary; Ovulation; Progesterone; Progesterone Congeners; Progestins | 1996 |
Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatment.
Topics: Administration, Oral; Androstenedione; Female; Hormone Antagonists; Humans; Hydrocortisone; Male; Meningioma; Mifepristone; Pituitary-Adrenal System; Prolactin; Thyroid Gland; Thyrotropin; Thyroxine; Time Factors; Triiodothyronine | 1997 |
New-D-homoandrost-4,6-diene derivatives as potent progesterone receptor antagonist.
Topics: Androgen Receptor Antagonists; Androstadienes; Androstenedione; Animals; Binding, Competitive; Corpus Luteum; Endometrium; Female; Gonadotropin-Releasing Hormone; Homosteroids; Hormone Antagonists; Male; Mice; Mifepristone; Molecular Structure; Ovary; Phenylacetates; Progesterone; Rabbits; Rats; Receptors, Androgen; Receptors, Progesterone; Structure-Activity Relationship; Uterus | 2010 |